KHALID MAZHAR SYED MD NPI 1528014289

NPI Information

  • NPI: 1528014289
  • Provider Name: KHALID MAZHAR SYED, MD
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 496 LYNNFIELD ST
    LYNN, MA
    ZIP 01904
  • Phone: (781) 593-3400

Map and Directions

Get Directions

NPI Details

Khalid Mazhar Syed, MD is a rheumatology internal medicine in Lynn, MA with 41 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Khalid Mazhar Syed, MD NPI is 1528014289. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

496 LYNNFIELD ST
LYNN, MA
ZIP 01904
Phone: (781) 593-3400
Fax: (781) 477-1195

The NPI 1528014289 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Methotrexate sodium, 5 mg (HCPCS:J9250)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Dxa bone density measurement of forearm, finger, hand, or foot (HCPCS:77081)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Influenza vaccine split virus, preservative free (HCPCS:90662)
  • Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Dxa bone density measurement of forearm, finger, hand, or foot (HCPCS:77081)
  • Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:Q0221)
  • Adm sarscv2 30mcg trs-sucr 3 (HCPCS:0053A)
  • Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:Q0220)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
  • Coronavirus vaccine 13 (HCPCS:91312)
  • Fee covid-19 vac 13 res (HCPCS:0124A)
  • Administration of pneumococcal vaccine (HCPCS:G0009)

The enumeration date for this NPI number is 5/25/2006 and was last updated on 8/18/2015.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal Medicine77575MASSACHUSETTSNo
2207RR0500XInternal MedicineRheumatology77575MASSACHUSETTSYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1110057233AMEDICAIDMASSACHUSETTS
2G07656MEDICARE UPIN
3A20318MEDICARE ID-TYPE UNSPECIFIED
43153258MEDICAIDMASSACHUSETTS
5A2031801MEDICARE PIN

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.